South Africa formulating vaccine strategy
Covering 10% of South Africa's roughly 58 million people through COVAX could cost around 2 billion rand.
Alexander WinningSouth Africa should aim to cover 10% of its population through a global coronavirus vaccine scheme while also negotiating directly with manufacturers, a group of e
...
As jy n aktiewe intekenaar is en die artikel wys nie, meld asseblief af en weer aan. Gratis toegang tot artikels vanaf 12:00.
Kommentaar
Republikein
Geen kommentaar is op hierdie artikel gelaat nie